My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 387

1.

Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats.

Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI.

Diabetes. 2002 Oct;51(10):2903-10.PMID: 12351425 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.

Henriksen EJ, Teachey MK.

Metabolism. 2007 Jul;56(7):931-8.PMID: 17570255 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Hammond ME, Harrison SD.

Diabetes. 2003 Mar;52(3):588-95.PMID: 12606497 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.

Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD.

Am J Physiol Endocrinol Metab. 2003 May;284(5):E892-900. Epub 2003 Jan 7.PMID: 12517738 [PubMed - indexed for MEDLINE]Related articlesFree article

5.

Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.

Dokken BB, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E207-13. Epub 2006 Feb 14.PMID: 16478771 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

Ruzzin J, Wagman AS, Jensen J.

Diabetologia. 2005 Oct;48(10):2119-30. Epub 2005 Aug 3.PMID: 16078016 [PubMed - indexed for MEDLINE]Related articles

7.

Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.

Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR.

Diabetes. 2002 Jul;51(7):2190-8.PMID: 12086949 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.

Pearce NJ, Arch JR, Clapham JC, Coghlan MP, Corcoran SL, Lister CA, Llano A, Moore GB, Murphy GJ, Smith SA, Taylor CM, Yates JW, Morrison AD, Harper AJ, Roxbee-Cox L, Abuin A, Wargent E, Holder JC.

Metabolism. 2004 Oct;53(10):1322-30.PMID: 15375789 [PubMed - indexed for MEDLINE]Related articles

9.

Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.

Liu Z, Wu Y, Nicklas EW, Jahn LA, Price WJ, Barrett EJ.

Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E523-8. Epub 2003 Dec 2.PMID: 14656717 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.

Henriksen EJ, Dokken BB.

Curr Drug Targets. 2006 Nov;7(11):1435-41. Review.PMID: 17100583 [PubMed - indexed for MEDLINE]Related articles

11.

Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.

Vestergaard H.

Dan Med Bull. 1999 Feb;46(1):13-34. Review.PMID: 10081651 [PubMed - indexed for MEDLINE]Related articles

12.

Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.

Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.

Br J Pharmacol. 1998 Dec;125(8):1708-14.PMID: 9886762 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.

Rossetti L, Lauglin MR.

J Clin Invest. 1989 Sep;84(3):892-9.PMID: 2503545 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle.

Lailerd N, Saengsirisuwan V, Sloniger JA, Toskulkao C, Henriksen EJ.

Metabolism. 2004 Jan;53(1):101-7.PMID: 14681850 [PubMed - indexed for MEDLINE]Related articles

15.

Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H.

Diabetologia. 1992 Jan;35(1):80-8.PMID: 1541385 [PubMed - indexed for MEDLINE]Related articles

16.

Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.

Vestergaard H, Lund S, Bjørbaek C, Pedersen O.

Diabetologia. 1995 Oct;38(10):1230-8.PMID: 8690177 [PubMed - indexed for MEDLINE]Related articles

17.

Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3.

Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E615-21. Epub 2007 Dec 18.PMID: 18089761 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.

Kaidanovich-Beilin O, Eldar-Finkelman H.

J Pharmacol Exp Ther. 2006 Jan;316(1):17-24. Epub 2005 Sep 16.PMID: 16169938 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR.

Diabetes. 2000 Feb;49(2):263-71.PMID: 10868943 [PubMed - indexed for MEDLINE]Related articlesFree article

20.

Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.

Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR.

Metabolism. 2000 Mar;49(3):400-10.PMID: 10726921 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity